Clinical Trial Update: Cetuximab in Head and Neck Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for cetuximab in head and neck squamous cell carcinoma has been completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Head and Neck Cancer, Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2023-05-24